Observational Study of Vismodegib (Erivedge) in Patients Treated in Argentina

CompletedOBSERVATIONAL
Enrollment

75

Participants

Timeline

Start Date

June 30, 2015

Primary Completion Date

July 26, 2017

Study Completion Date

July 26, 2017

Conditions
Basal Cell Carcinoma
All Listed Sponsors
lead

Hoffmann-La Roche

INDUSTRY

NCT02438644 - Observational Study of Vismodegib (Erivedge) in Patients Treated in Argentina | Biotech Hunter | Biotech Hunter